Invasive Aspergillosis in Neutropenic Patients with Hematological Disorders

Area of Science:

• Hematology
• Infectious Diseases
• Mycology

Background:

• Invasive aspergillosis is a serious fungal infection often seen in immunocompromised patients.
• Neutropenia, a common side effect of chemotherapy for acute leukemia and aplastic anemia, increases susceptibility.
• Early diagnosis and treatment are critical for improving patient outcomes.

Purpose of the Study:

• To evaluate the incidence and outcomes of invasive aspergillosis in patients with acute leukemia and aplastic anemia.
• To assess the effectiveness of antifungal treatment, specifically amphotericin B, in this patient population.
• To identify factors influencing survival in invasive aspergillosis.

Main Methods:

• Retrospective analysis of 72 acute leukemia and 4 aplastic anemia patients treated between 1983-1988.
• Diagnosis of invasive aspergillosis based on clinical, radiological, and microbiological findings (sputum cultures, tissue cultures).
• Evaluation of treatment response and survival rates in relation to antifungal therapy and neutrophil recovery.

Main Results:

• Ten acute leukemia patients developed pulmonary aspergillosis; 5 achieved remission with antifungal treatment and recovered, while 5 died.
• Two aplastic anemia patients developed invasive aspergillosis of the nose and paranasal sinuses; both died despite antifungal treatment.
• Successful treatment outcomes were associated with early amphotericin B administration and neutrophil count recovery.

Conclusions:

• Invasive aspergillosis in neutropenic patients is potentially curable with timely amphotericin B treatment and neutrophil recovery.
• Neutropenic patients with acute leukemia and aplastic anemia are at high risk for invasive aspergillosis.
• Prompt diagnosis and aggressive antifungal therapy are essential for improving survival rates.